Guardant Health

Guardant HealthGuardant Health
Guardant Health

Guardant Health

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Website
DR 712012Active4663Redwood City, United States
Rate
Advertise here

About

Guardant Health is a leading precision oncology company focused on transforming cancer management through its proprietary liquid biopsy technology. Their tests analyze circulating tumor DNA (ctDNA) from a simple blood draw to provide comprehensive genomic insights for patients with advanced cancer, enabling earlier detection, more effective treatment selection, and recurrence monitoring.
HEADCOUNT
4663
DOMAIN RATING
71
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Guardant Health do?

Guardant Health is a leading precision oncology company focused on transforming cancer management through its proprietary liquid biopsy technology. Their tests analyze circulating tumor DNA (ctDNA) from a simple blood draw to provide comprehensive genomic insights for patients with advanced cancer, enabling earlier detection, more effective treatment selection, and recurrence monitoring.

How much funding has Guardant Health raised?

Guardant Health has raised a total of $900M in funding. The most recent round on record is Post IPO.

Where is Guardant Health headquartered?

Guardant Health is headquartered in Redwood City, United States.

When was Guardant Health founded?

Guardant Health was founded in 2012.

What industry does Guardant Health operate in?

Guardant Health operates in Biotech, MedTech, HealthTech, Genomics, Oncology, Liquid Biopsy.

How many employees does Guardant Health have?

Guardant Health has approximately 4663 people on record.

What is Guardant Health's revenue?

StartupHub estimates Guardant Health's annual revenue at $476.0M (range $264.2M to $1.9B, 64% confidence), based on comparable companies in the sector.

What is Guardant Health's valuation?

StartupHub estimates Guardant Health's effective valuation at $3.5B (range $2.3B to $5.4B, 19% confidence), based on comparable companies in the sector.